Moving downstream in the NLRP3 inflammasome pathway, IL-1 is a major mediator of inflammation in various pathologic states, such as autoinflammatory diseases (familial Mediterranean fever), acute infections, and chronic inflammatory environments, such as cancer and atherosclerosis [31]. Here, NLRP3 is linked to atherosclerosis.